Skip to the page

Data / Form D filings / BioFlyte, Inc.

BioFlyte, Inc.: Form D filing

BioFlyte, Inc., a technology company in Albuquerque, NM, filed a Form D with the SEC in 2023. The latest, on September 7, 2023, reports $5.4 million sold of a $7 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10510 RESEARCH ROAD SE, Albuquerque, NM, 87123
Phone
(703) 946-6233
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1987670

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 7, 2023New notice$7,000,000$5,400,000$1,600,0006Dec 16, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
David BlivinDirector
Bradley HarrisonDirector
David SeldinDirector
Todd SicklesExecutive Officer, Director
John BoltonDirector
Jenna AbelliDirector

Every Form D from the week of Sep 4, 2023 · All recent filings in New Mexico · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what BioFlyte, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.